<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In addition to problems with mastitis, there is also concern that rbST treatment may increase the risk of lameness and foot and leg disorders. While many early studies failed to find a detectable difference between rbST treated and control animals [
 <xref rid="B121-animals-05-00361" ref-type="bibr" class="xref">121</xref>,
 <xref rid="B125-animals-05-00361" ref-type="bibr" class="xref">125</xref>,
 <xref rid="B126-animals-05-00361" ref-type="bibr" class="xref">126</xref>,
 <xref rid="B127-animals-05-00361" ref-type="bibr" class="xref">127</xref>,
 <xref rid="B128-animals-05-00361" ref-type="bibr" class="xref">128</xref>,
 <xref rid="B129-animals-05-00361" ref-type="bibr" class="xref">129</xref>], others found a slight increase in the number of cows culled due to lameness [
 <xref rid="B130-animals-05-00361" ref-type="bibr" class="xref">130</xref>] and slightly more feet and leg problems [
 <xref rid="B130-animals-05-00361" ref-type="bibr" class="xref">130</xref>,
 <xref rid="B131-animals-05-00361" ref-type="bibr" class="xref">131</xref>]. As with the early work on mastitis and rbST, in studies with small cow numbers, low statistical power may have prevented detection of effects, and slight increases would be hard to find.
</p>
